Mother-to-child transmission of the human immunodeficiency virus in Texas

Pediatric Infectious Disease Journal

Volumn 20, Issue 6, 2001, Pages 602-606

  Arbona, Sonia I ^a,j   Melville, Sharon K ^a   Hanson, I CELINE ^c   Squires, Janet E ^e   Doyle, Marilyn ^d   Doran, Terence I ^f   Patel, Janak A ^g   Handal, Gilberto A ^h   Hauger, Sarmistha B ^b   Murphey, Donald K ^e   Dominguez, Kenneth ⁱ  

^a TEXAS DEPARTMENT OF STATE HEALTH SERVICES   (United States)

^b Children's Hospital of Austin   (United States)

^c Baylor Texas Children's Hospital   (United States)

^d UNIVERSITY OF TEXAS   (United States)

^e Children's Medical Center   (United States)

^f UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^g UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^h Texas Tech Medical Center   (United States)

ⁱ CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^j Bureau of HIV and STD Prevention   (United States)

more..

Author keywords

Human immunodeficiency virus; Mother to child; Texas

Indexed keywords

ZIDOVUDINE;

ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RATE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MATERNAL CARE; POSTNATAL CARE; PRENATAL CARE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; UNITED STATES; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

ANTI-HIV AGENTS; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV INFECTIONS; HUMANS; INFANT, NEWBORN; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE; RISK FACTORS; TEXAS; ZIDOVUDINE;

EID: 0034966887     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200106000-00011     Document Type: Article

References (18)

1. Prevention and treatment of pediatric HIV infection
2. Trends in perinatal transmission of HIV/AIDS in the United States
3. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment
4. 1994 Revised classification system for human immunodeficiency virus infection in children <13 years of age
5. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1: A meta-analysis of 15 prospective cohort studies
6. Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus
7. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine
8. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission
9. Uninsured in an era of managed care
10. National profile on access to medical care: Where do we stand?